 Parsippany, NJ, Nov. 25, 2020 GLOBE NEWSWIRE -- Interpace Biosciences, Inc. NASDAQ: IDXG today announced that Jack Stover, President Chief Executive Officer, will retire effective December 31, 2020. He will be replaced as President and Chief Executive Officer by Thomas Burnell, PhD., effective December 1, 2020. Mr. Stover, who will step down from the Interpace Board of Directors once Dr. Burnell joins the company and is appointed to the Board, will serve as an advisor to the company through the middle of 2021 in order to support the transition. 